What is Legal Insider Trading? How do I use this site?
Learn More ›
Login/Signup
Top Companies
Form Screener
Random Insider
Random Company
Sectors
FAQ
Feedback
Blog
Pricing
Nurix Therapeutics, Inc. (NRIX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
SELL
30 Apr 2023
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
10,040
-6%
682
$9.88
$6,735.64
SELL
30 Apr 2023
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
26,632
-4%
1,136
$9.88
$11,219.48
SELL
30 Apr 2023
Wolff Stefani
EVP and COO, Officer
Nurix Therapeutics, Inc.
(NRIX)
6,113
-5%
342
$9.88
$3,377.69
SELL
30 Apr 2023
van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
78,930
-0%
721
$9.88
$7,120.81
SELL
30 Jan 2023
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
23,009
-5%
1,412
$11.78
$16,632.80
SELL
30 Jan 2023
van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
76,765
-1%
924
$11.78
$10,884.35
SELL
30 Jan 2023
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
7,261
-10%
848
$11.78
$9,989.10
SELL
30 Jan 2023
Wolff Stefani
EVP and COO, Officer
Nurix Therapeutics, Inc.
(NRIX)
3,940
-9%
424
$11.78
$4,994.55
SELL
30 Oct 2022
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
21,214
-5%
1,165
$12.88
$15,005.78
SELL
30 Oct 2022
Wolff Stefani
EVP and COO, Officer
Nurix Therapeutics, Inc.
(NRIX)
3,402
-9%
350
$12.88
$4,508.18
SELL
30 Oct 2022
van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
74,803
-0%
739
$12.88
$9,518.69
SELL
30 Oct 2022
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
6,185
-10%
699
$12.88
$9,003.47
SELL
30 Jul 2022
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
4,615
-13%
712
$15.67
$11,157.04
SELL
30 Jul 2022
Wolff Stefani
EVP and COO, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,238
-22%
356
$15.67
$5,578.52
SELL
30 Jul 2022
van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
72,656
-1%
752
$15.67
$11,783.84
SELL
30 Jul 2022
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
19,172
-5%
1,186
$15.67
$18,584.62
SELL
30 Apr 2022
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
17,151
-6%
1,098
$11.75
$12,901.50
SELL
30 Apr 2022
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
3,403
-16%
660
$11.75
$7,755.00
SELL
30 Apr 2022
Wolff Stefani
EVP and COO, Officer
Nurix Therapeutics, Inc.
(NRIX)
632
-34%
330
$11.75
$3,877.50
SELL
30 Apr 2022
van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
2,189
-24%
697
$11.75
$8,189.75
SELL
10 Jan 2022
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286
-48%
1,200
$27.14
$32,568.00
SELL
3 Jan 2022
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197
-11%
1,828
$28.96
$52,938.88
SELL
10 Dec 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286
-48%
1,200
$29.04
$34,848.00
SELL
1 Dec 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197
-2%
400
$29.13
$11,652.00
SELL
10 Nov 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286
-48%
1,200
$32.38
$38,856.00
SELL
1 Nov 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197
-2%
400
$33.24
$13,296.00
SELL
27 Oct 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197
-2%
400
$35.00
$14,000.00
SELL
27 Oct 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286
-38%
800
$35.25
$28,200.00
SELL
11 Oct 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286
-48%
1,200
$27.36
$32,832.00
SELL
1 Oct 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197
-2%
400
$29.92
$11,968.00
SELL
10 Sep 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
2,586
-43%
2,000
$35.93
$71,860.16
SELL
7 Sep 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197
-10%
1,600
$35.00
$56,000.00
SELL
7 Sep 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286
-71%
3,200
$35.25
$112,800.00
SELL
1 Sep 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197
-2%
400
$32.34
$12,936.00
SELL
10 Aug 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
805
-59%
1,200
$29.87
$35,844.96
SELL
10 Aug 2021
Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
6,210
-54%
7,500
$29.86
$223,925.94
SELL
2 Aug 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804
-2%
400
$31.21
$12,484.00
SELL
20 Jul 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
805
-59%
1,200
$27.00
$32,400.00
SELL
12 Jul 2021
Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
4,730
-61%
7,500
$23.92
$179,418.70
SELL
1 Jul 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804
-2%
400
$26.76
$10,704.00
SELL
10 Jun 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,005
-54%
1,200
$29.40
$35,282.00
SELL
10 Jun 2021
Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
5,830
-56%
7,500
$29.37
$220,248.50
SELL
1 Jun 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804
-2%
400
$27.74
$11,096.00
SELL
10 May 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
805
-59%
1,200
$27.00
$32,400.00
SELL
10 May 2021
Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
7,531
-49%
7,500
$26.49
$198,644.22
SELL
3 May 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804
-5%
800
$35.00
$27,996.00
SELL
28 Apr 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
805
-49%
800
$35.25
$28,200.00
SELL
12 Apr 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
805
-59%
1,200
$27.20
$32,640.00
SELL
12 Apr 2021
Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
7,758
-49%
7,500
$27.28
$204,631.89
SELL
5 Apr 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804
-2%
400
$35.00
$14,000.00
SELL
1 Apr 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804
-2%
400
$31.55
$12,620.00
SELL
16 Mar 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804
-5%
800
$45.00
$36,000.00
SELL
10 Mar 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,905
-51%
2,000
$41.27
$82,539.37
SELL
8 Mar 2021
Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
4,690
-61%
7,500
$37.02
$277,678.50
SELL
1 Mar 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804
-5%
800
$35.95
$28,760.00
SELL
24 Feb 2021
van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
0
-100%
35,419
$39.90
$1,413,218.10
SELL
22 Feb 2021
van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
0
-100%
5,330
$39.93
$212,839.16
SELL
18 Feb 2021
Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
12,200
-6%
800
$36.27
$29,018.02
SELL
18 Feb 2021
Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,600
-55%
2,000
$35.88
$71,750.35
SELL
18 Feb 2021
Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
12,353
-54%
15,000
$35.49
$532,351.75
SELL
18 Feb 2021
van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
10,443
-56%
13,583
$35.46
$481,621.03
Home